- Home
- / Product Brochures
- / Simoa® p-Tau 217 Fact Sheet
Phosphorylated Tau 217 (p-Tau 217) is proving to be a crucial biomarker for Alzheimer’s disease and other neurodegenerative disorders. Tau proteins play a pivotal role in maintaining the stability of neuronal microtubules, which are essential for normal brain function. In Alzheimer’s disease, tau proteins can become hyperphosphorylated, leading to the formation of neurofibrillary tangles, a hallmark of the disease. This abnormal phosphorylation is associated with neuronal damage, cognitive decline, and cell death.
Research indicates that p-Tau 217 levels in cerebrospinal fluid (CSF) and blood are significantly elevated in patients with Alzheimer’s, even in the early stages. This positions it as a valuable potential biomarker for early diagnosis and monitoring disease progression. Furthermore, studies have shown that p-Tau 217 can help differentiate Alzheimer’s disease from other forms of dementia, such as Lewy body dementia and frontotemporal dementia. Download our fact sheet to learn more.
Share This Post
Related Posts
Akoya PhenoImager-HT 2.0 Brochure
Human Neurobiology PhenoCode Discovery Panel
Building Custom High-Plex Biomarker Panels
Scale Your Spatial Discoveries with Molecular Barcoding
Spatial Analysis
PhenoCode Molecular Barcoding Kit
Introducing the Metabolism Spike-in Module for IO60
NfL Fact Sheet
Neurofilament light (NfL) has emerged in recent years as a blood-based biomarker with the potential to aid in the improvement of early diagnosis and patient care of neuro-axonal injury and…
Neurology
Cytokine 4-Plex Advantage PLUS Product Flyer
Ultra-Sensitive, Fully Automated Simoa® Cytokine 4-Plex Advantage PLUS Assays Three panels, 11 essential cytokine biomarkers, femtogram sensitivity With Simoa® ultra-sensitive protein quantification, the cutting-edge Advantage PLUS assay platform, and full…